In-silico discovery of common molecular signatures for which SARS-CoV-2 infections and lung diseases stimulate each other, and drug repurposing.

MLA

Alamin, Muhammad Habibulla, et al. “In-Silico Discovery of Common Molecular Signatures for Which SARS-CoV-2 Infections and Lung Diseases Stimulate Each Other, and Drug Repurposing.” PloS One, vol. 19, no. 7, July 2024, p. e0304425. EBSCOhost, https://doi.org/10.1371/journal.pone.0304425.

APA

Alamin, M. H., Rahaman, M. M., Ferdousi, F., Sarker, A., Ali, M. A., Hossen, M. B., Sarker, B., Kumar, N., & Mollah, M. N. H. (2024). In-silico discovery of common molecular signatures for which SARS-CoV-2 infections and lung diseases stimulate each other, and drug repurposing. PloS One, 19(7), e0304425. https://doi.org/10.1371/journal.pone.0304425

Chicago

Alamin, Muhammad Habibulla, Md Matiur Rahaman, Farzana Ferdousi, Arnob Sarker, Md Ahad Ali, Md Bayazid Hossen, Bandhan Sarker, Nishith Kumar, and Md Nurul Haque Mollah. 2024. “In-Silico Discovery of Common Molecular Signatures for Which SARS-CoV-2 Infections and Lung Diseases Stimulate Each Other, and Drug Repurposing.” PloS One 19 (7): e0304425. doi:10.1371/journal.pone.0304425.